Filing Details
- Accession Number:
- 0001140361-17-033128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-23 20:26:27
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-23 19:26:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594337 | Corium International Inc. | CORI | Pharmaceutical Preparations (2834) | 383230774 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603700 | Parminder Singh | C/O Corium International, Inc. 235 Constituion Drive Menlo Park CA 94025 | Cto & Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-21 | 7,593 | $7.53 | 30,762 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-22 | 22,822 | $7.61 | 7,940 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.89 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
